Apolipoprotein A1 as a novel anti-implantation biomarker in polycystic ovary syndrome: A case-control study

Apolipoprotein A1 as a novel anti-implantation biomarker in polycystic ovary syndrome: A case-control study

Background: Women with polycystic ovary syndrome have lower pregnancy rates, possibly due to the decreased uterine receptivity. Successful implantation depends on protein networks that are essential for cross-talk between the embryo and endometrium. Apolipoprotein A1 has been proposed as a putative...

Full description

Bibliographic Details
Main Authors: Fatemehsadat Amjadi, Reza Aflatoonian, Shaghayegh Haghjoo Javanmard, Bita Saifi, Mahnaz Ashrafi, Mehdi Mehdizadeh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Apolipoprotein A1
endometrium
polycystic ovary syndrome
proliferative phase
secretory phase
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2015;volume=20;issue=11;spage=1039;epage=1045;aulast=Amjadi

Internet

http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2015;volume=20;issue=11;spage=1039;epage=1045;aulast=Amjadi

Similar Items